Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Teun van Gelder

Showing results (31-40 of 324) with videos related to

Pageof 33
Sort By:
Transplantation Reviews (Orlando, Fla.)|June 7, 2015
Pharmacokinetics and pharmacodynamics of immunosuppressive drugs in elderly kidney transplant recipientsYun-Ying Shi, Dennis A Hesselink, Teun van Gelder
Transplantation|May 13, 2011
Relationship of tacrolimus exposure and mycophenolate mofetil dose with renal function after renal transplantationHenrik Ekberg, Teun van Gelder, Bruce Kaplan, et al.
JAMA Internal Medicine|October 6, 2015
Selecting the Optimal Design for Drug Discontinuation Trials in a Setting of Advanced, Life-Limiting IllnessEric C T Geijteman, Henning Tiemeier, Teun van Gelder
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 10, 2014
To TDM or not to TDM in lupus nephritis patients treated with MMF?Teun van Gelder, Jo H M Berden, Stefan P Berger
Expert Review of Clinical Pharmacology|June 28, 2022
Voclosporin: a novel calcineurin inhibitor for the treatment of lupus nephritisTeun van Gelder, Edgar Lerma, Kory Engelke, et al.
Nature Reviews. Nephrology|September 24, 2014
Pharmacogenetics and immunosuppressive drugs in solid organ transplantationTeun van Gelder, Ron H van Schaik, Dennis A Hesselink
Pharmacogenomics|July 12, 2005
The pharmacogenetics of calcineurin inhibitors: one step closer toward individualized immunosuppression?Dennis A Hesselink, Teun van Gelder, Ron Hn van Schaik
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 2, 2021
Voclosporin: a novel calcineurin inhibitor with no impact on mycophenolic acid levels in patients with SLETeun van Gelder, Robert B Huizinga, Laura Lisk, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 5, 2013
Report of the second joint meeting of ESOT and AST: current pipelines in biotech and pharmaTeun van Gelder, Carla Baan, Flavio Vincenti, et al.
JAMA Internal Medicine|January 27, 2015
Sense and nonsense of treatment of comorbid diseases in terminally ill patientsEric C T Geijteman, Teun van Gelder, Lia van Zuylen
Pageof 33

Showing results (31-40 of 324) with videos related to

Sort By:
Pageof 33
Transplantation Reviews (Orlando, Fla.)|June 7, 2015
Pharmacokinetics and pharmacodynamics of immunosuppressive drugs in elderly kidney transplant recipientsYun-Ying Shi, Dennis A Hesselink, Teun van Gelder
Transplantation|May 13, 2011
Relationship of tacrolimus exposure and mycophenolate mofetil dose with renal function after renal transplantationHenrik Ekberg, Teun van Gelder, Bruce Kaplan, et al.
JAMA Internal Medicine|October 6, 2015
Selecting the Optimal Design for Drug Discontinuation Trials in a Setting of Advanced, Life-Limiting IllnessEric C T Geijteman, Henning Tiemeier, Teun van Gelder
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|May 10, 2014
To TDM or not to TDM in lupus nephritis patients treated with MMF?Teun van Gelder, Jo H M Berden, Stefan P Berger
Expert Review of Clinical Pharmacology|June 28, 2022
Voclosporin: a novel calcineurin inhibitor for the treatment of lupus nephritisTeun van Gelder, Edgar Lerma, Kory Engelke, et al.
Nature Reviews. Nephrology|September 24, 2014
Pharmacogenetics and immunosuppressive drugs in solid organ transplantationTeun van Gelder, Ron H van Schaik, Dennis A Hesselink
Pharmacogenomics|July 12, 2005
The pharmacogenetics of calcineurin inhibitors: one step closer toward individualized immunosuppression?Dennis A Hesselink, Teun van Gelder, Ron Hn van Schaik
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 2, 2021
Voclosporin: a novel calcineurin inhibitor with no impact on mycophenolic acid levels in patients with SLETeun van Gelder, Robert B Huizinga, Laura Lisk, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|July 5, 2013
Report of the second joint meeting of ESOT and AST: current pipelines in biotech and pharmaTeun van Gelder, Carla Baan, Flavio Vincenti, et al.
JAMA Internal Medicine|January 27, 2015
Sense and nonsense of treatment of comorbid diseases in terminally ill patientsEric C T Geijteman, Teun van Gelder, Lia van Zuylen
Pageof 33